BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38687465)

  • 1. Inhibition of Human Colorectal Cancer by a Natural Product 7-Acetylhorminone and Interactions with BSA/HSA: Multispectral Analysis and In Silico and In Vitro Studies.
    Pakrashy S; Chakraborty S; Manna S; Nanda Goswami J; Bhattacharya B; Emmerling F; Mandal J; Misra S; Maiti Choudhury S; Okla MK; Bose A; Maurya PK; Majhi A; Dolai M
    ACS Appl Bio Mater; 2024 May; 7(5):3414-3430. PubMed ID: 38687465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological evaluations of newly-designed Pt(II) and Pd(II) complexes using spectroscopic and molecular docking approaches.
    Ghalandari B; Poursoleiman A; Fekri M; Komeili A; Divsalar A; Eslami Moghadam M; Kamrava SK; Saboury AA
    J Biomol Struct Dyn; 2019 Aug; 37(13):3422-3433. PubMed ID: 30146941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multispectroscopic insight, morphological analysis and molecular docking studies of Cu
    Yousuf I; Bashir M; Arjmand F; Tabassum S
    J Biomol Struct Dyn; 2019 Aug; 37(12):3290-3304. PubMed ID: 30124142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the interaction of fisetholz with BSA/HSA by multi-spectroscopic, cyclic voltammetric, and molecular docking technique.
    Wu J; Bi SY; Sun XY; Zhao R; Wang JH; Zhou HF
    J Biomol Struct Dyn; 2019 Aug; 37(13):3496-3505. PubMed ID: 30176766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mono- and bis-pyrazolophthalazines: Design, synthesis, cytotoxic activity, DNA/HSA binding and molecular docking studies.
    Hamidinasab M; Ameri A; Hekmat A; Forootanfar H; Mortezazadeh T; Bodaghifard MA; Peytam F; Esmaeili R; Foroumadi A; Sharifzadeh M; Mobinikhaledi A; Khoobi M
    Bioorg Med Chem; 2021 Jan; 30():115944. PubMed ID: 33352388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multispectroscopic and molecular docking investigation of the binding interaction between serum albumins and acid orange dye.
    Naveenraj S; Solomon RV; Mangalaraja RV; Venuvanalingam P; Asiri AM; Anandan S
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Mar; 192():34-40. PubMed ID: 29126006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the interaction of thionine with human serum albumin by multispectroscopic studies and its in vitro cytotoxic activity toward MCF-7 breast cancer cells.
    Manivel P; Paulpandi M; Murugan K; Benelli G; Ilanchelian M
    J Biomol Struct Dyn; 2017 Nov; 35(14):3012-3031. PubMed ID: 27691050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the binding interactions of janus green blue with serum albumins from spectroscopic and calorimetric studies aided by
    Saha S; Bhattacharjee S; Chowdhury J
    J Biomol Struct Dyn; 2022 Aug; 40(12):5328-5344. PubMed ID: 33410370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure elucidation of novel salophen-based dioxo-uranium(VI) complexes: In-vitro and in-silico studies of their DNA/BSA-binding properties and anticancer activity.
    Ebrahimipour SY; Mohamadi M; Torkzadeh Mahani M; Simpson J; Mague JT; Sheikhshoaei I
    Eur J Med Chem; 2017 Nov; 140():172-186. PubMed ID: 28923384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multispectral and computational probing of the interactions between sitagliptin and serum albumin.
    Shaghaghi M; Dehghan G; Rashtbari S; Sheibani N; Aghamohammadi A
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Dec; 223():117286. PubMed ID: 31302563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the binding site and mechanism of new methylene blue with serum albumins: A multispectroscopic and computational investigation.
    Manivel P; Marimuthu P; Ilanchelian M
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Nov; 300():122900. PubMed ID: 37244028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multispectral and molecular docking investigations on the interaction of primethamine/trimethoprim with BSA/HSA.
    Sun X; Bi S; Wu J; Zhao R; Shao D; Song Z
    J Biomol Struct Dyn; 2020 Feb; 38(3):934-942. PubMed ID: 30843766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin binding, anticancer and antibacterial properties of synthesized zero valent iron nanoparticles.
    Anbouhi TS; Esfidvajani EM; Nemati F; Haghighat S; Sari S; Attar F; Pakaghideh A; Sohrabi MJ; Mousavi SE; Falahati M
    Int J Nanomedicine; 2019; 14():243-256. PubMed ID: 30643404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of hexacyanoferrate(II)/(III) charge-dependent interactions with bovine and human serum albumins.
    Grabowska O; Samsonov SA; Chmurzyński L; Wyrzykowski D; Żamojć K
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 May; 293():122505. PubMed ID: 36809739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interaction of 2,4-diacetylphloroglucinol (DAPG) with human serum albumin (HSA): The spectroscopic, calorimetric and computational investigation.
    T PL; Mondal M; Ramadas K; Natarajan S
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Aug; 183():90-102. PubMed ID: 28441541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cytotoxicity and DNA/HSA interaction study of triamterene using molecular modelling and multi-spectroscopic methods.
    Moghadam NH; Salehzadeh S; Tanzadehpanah H; Saidijam M; Karimi J; Khazalpour S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2242-2253. PubMed ID: 30043689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interactions between warfarin and human (HSA) or bovine (BSA) serum albumin evaluated by isothermal titration calorimetry (ITC), fluorescence spectrometry (FS) and frontal analysis capillary electrophoresis (FA/CE).
    Ràfols C; Amézqueta S; Fuguet E; Bosch E
    J Pharm Biomed Anal; 2018 Feb; 150():452-459. PubMed ID: 29291587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation.
    Alos HC; Billones JB; Castillo AL; Vasquez RD
    Daru; 2022 Dec; 30(2):273-288. PubMed ID: 35925539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular interactions and binding dynamics of Alpelisib with serum albumins: insights from multi-spectroscopic techniques and molecular docking.
    Jalan A; Moyon NS
    J Biomol Struct Dyn; 2024; 42(4):2127-2143. PubMed ID: 37098825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.